Literature DB >> 15308480

Contributions of LFA-1 and Mac-1 to brain injury and microvascular dysfunction induced by transient middle cerebral artery occlusion.

Thiruma V Arumugam1, James W Salter, John H Chidlow, Christie M Ballantyne, Christopher G Kevil, D Neil Granger.   

Abstract

Although the beta2-integrins have been implicated in the pathogenesis of cerebral ischemia-reperfusion (I/R) injury, the relative contributions of the alpha-subunits to the pathogenesis of ischemic stroke remains unclear. The objective of this study was to determine whether and how genetic deficiency of either lymphocyte function-associated antigen-1 (LFA-1) or macrophage-1 (Mac-1) alters the blood cell-endothelial cell interactions, tissue injury, and organ dysfunction in the mouse brain exposed to focal I/R. Middle cerebral artery occlusion was induced for 1 h (followed by either 4 or 24 h of reperfusion) in wild-type mice and in mice with null mutations for either LFA-1 or Mac-1. Neurological deficit and infarct volume were monitored for 24 h after reperfusion. Platelet- and leukocyte-vessel wall adhesive interactions were monitored in cortical venules by intravital microscopy. Mice with null mutations for LFA-1 or Mac-1 exhibited significant reductions in infarct volume. This was associated with a significant improvement in the I/R-induced neurological deficit. Leukocyte adhesion in cerebral venules did not differ between wild-type and mutant mice at 4 h after reperfusion. However, after 24 h of reperfusion, leukocyte adhesion was reduced in both LFA-1- and Mac-1-deficient mice compared with their wild-type counterparts. Platelet adhesion was also reduced at both 4 and 24 h after reperfusion in the LFA-1- and Mac-1-deficient mice. These findings indicate that both alpha-subunits of the beta2-integrins contribute to the brain injury and blood cell-vessel wall interactions that are associated with transient focal cerebral ischemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15308480     DOI: 10.1152/ajpheart.00588.2004

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  40 in total

Review 1.  Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.

Authors:  T V Arumugam; T M Woodruff; J D Lathia; P K Selvaraj; M P Mattson; S M Taylor
Journal:  Neuroscience       Date:  2008-07-12       Impact factor: 3.590

Review 2.  Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke.

Authors:  Changjun Yang; Kimberly E Hawkins; Sylvain Doré; Eduardo Candelario-Jalil
Journal:  Am J Physiol Cell Physiol       Date:  2018-10-31       Impact factor: 4.249

Review 3.  Myeloid cells as therapeutic targets in neuroinflammation after stroke: Specific roles of neutrophils and neutrophil-platelet interactions.

Authors:  Alicia García-Culebras; Violeta Durán-Laforet; Carolina Peña-Martínez; Iván Ballesteros; Jesús M Pradillo; Jaime Díaz-Guzmán; Ignacio Lizasoain; María A Moro
Journal:  J Cereb Blood Flow Metab       Date:  2018-08-21       Impact factor: 6.200

4.  Soluble neuroprotective antioxidant uric acid analogs ameliorate ischemic brain injury in mice.

Authors:  Frank Haberman; Sung-Chun Tang; Thiruma V Arumugam; Dong-Hoon Hyun; Qian-Sheng Yu; Roy G Cutler; Zhihong Guo; Harold W Holloway; Nigel H Greig; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2007-08-10       Impact factor: 3.843

Review 5.  Immune Cells After Ischemic Stroke Onset: Roles, Migration, and Target Intervention.

Authors:  Lu-Yao Ao; Yun-Yi Yan; Lin Zhou; Cheng-Yuan Li; Wan-Ting Li; Wei-Rong Fang; Yun-Man Li
Journal:  J Mol Neurosci       Date:  2018-10-01       Impact factor: 3.444

6.  Noggin protects against ischemic brain injury in rodents.

Authors:  Jayshree Samanta; Tord Alden; Kevin Gobeske; Lixin Kan; John A Kessler
Journal:  Stroke       Date:  2009-12-17       Impact factor: 7.914

Review 7.  Phytochemicals in Ischemic Stroke.

Authors:  Joonki Kim; David Yang-Wei Fann; Raymond Chee Seong Seet; Dong-Gyu Jo; Mark P Mattson; Thiruma V Arumugam
Journal:  Neuromolecular Med       Date:  2016-05-18       Impact factor: 3.843

Review 8.  Cell adhesion molecules and ischemic stroke.

Authors:  Gokhan Yilmaz; D Neil Granger
Journal:  Neurol Res       Date:  2008-10       Impact factor: 2.448

9.  Inhibition of CD147 (Cluster of Differentiation 147) Ameliorates Acute Ischemic Stroke in Mice by Reducing Thromboinflammation.

Authors:  Rong Jin; Adam Y Xiao; Rui Chen; D Neil Granger; Guohong Li
Journal:  Stroke       Date:  2017-11-07       Impact factor: 7.914

10.  The value of leukocyte adhesion molecules in patients after ischemic stroke.

Authors:  Nai-Wen Tsai; Wen-Neng Chang; Chen-Fu Shaw; Chung-Ren Jan; Chi-Ren Huang; Shang-Der Chen; Yao-Chung Chuang; Lian-Hui Lee; Cheng-Hsien Lu
Journal:  J Neurol       Date:  2009-04-08       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.